FDA Approved: MONTELUKAST SODIUM — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved the original application for a generic montelukast sodium product from Rising Pharma Holdings, Inc. under ANDA 202468.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma
• Exercise-induced Bronchoconstriction
• Seasonal Allergic Rhinitis

Drugs mentioned

• Montelukast Sodium (Montelukast Sodium)

Snippet

ORIG AP for MONTELUKAST SODIUM (MONTELUKAST SODIUM)